FDA Approves New Drug to Slow Alzheimer's Disease
The FDA today approved a new therapy for early Alzheimer's disease that appears to modestly slow the progression of the disease that affects more than 6.5 million Americans.
Stay updated with breaking news from Cognitive Deficit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA today approved a new therapy for early Alzheimer's disease that appears to modestly slow the progression of the disease that affects more than 6.5 million Americans.
An insomnia medication has been linked to lower levels of Alzheimer's pathology in humans, results of a small proof-of-concept study show.
Are the monotonous routines of residential facilities worsening negative symptoms for some patients with schizophrenia? Investigators suspect so.
A small proof-of-concept study singles out obstructive sleep apnea, not its comorbidities, as the possible culprit in cognitive decline.
Food insecurity in older adults is linked to a more rapid decline in executive function, a new study shows.